All In MedTech

Company

Spectranetics

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Spectranetics, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Spectranetics we have 3 government grants totalling $148K.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

The 8 newest of 17 since 2015.

Search the Clearance Tracker

14 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT02769273 · 1,900 participants · Start Jun 2016 · Primary completion Oct 31, 2021

    Device: Percutaneous Transluminal Angioplasty · For: Peripheral Arterial Disease

    Sites: Graz, Austria; Ried im Innkreis, Austria; Vienna, Austria · 46 sites in all

  • NCT05361967 · 6 participants · Start Mar 30, 2023 · Primary completion Jun 1, 2024

    Device: The Tack Endovascular System · For: PAD - Peripheral Arterial Disease; PAD; Dissection and 3 more

    Sites: Thornton, Colorado; Hartford, Connecticut; Fort Lauderdale, Florida · 10 sites in all

  • NCT03421561 · 300 participants · Start Jun 18, 2013 · Primary completion Dec 8, 2017

    Device: Stellarex 0.035" OTW Drug-coated Angioplasty Balloon; EverCross™ 0.035 PTA Balloon Catheter · For: Peripheral Artery Disease

    Sites: Yuma, Arizona; Fremont, California; Los Angeles, California · 41 sites in all

15 more trials with a free account

Reports received

586

Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.

Malfunction reports

99

17% of reports

Injury reports

370

63% of reports

Death reports

116

20% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2311920
Jan 2451710
Feb 2441260
Mar 2491230
Apr 2451320
May 24102150
Jun 2432100
Jul 2431120
Aug 2441930
Sep 2471230
Oct 2461220
Nov 2421320
Dec 2481040
Jan 2531810
Feb 2571310
Mar 2551120
Apr 2592140
May 2551420
Jun 258520
Jul 2562680
Aug 253410
Sep 2582520
Oct 2582540
Nov 2510911
Dec 2531640
Jan 2672140
Feb 26102450
Mar 26142590
Apr 26847130
May 26661260
Jun 268102310
Jul 26101470
Aug 26111520
Sep 2662380
Oct 2661360
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

6 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

18 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.